These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 10037445)

  • 61. Substrate specificity of a hypothalamic neurosecretory granule enzyme capable of processing pro-gonadotropin releasing hormone precursor protein.
    Palen TE; Harris RB; Wypij DM; Wilson IB
    Peptides; 1987; 8(1):21-4. PubMed ID: 3554167
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Proline rich-oligopeptides: diverse mechanisms for antihypertensive action.
    Morais KL; Ianzer D; Miranda JR; Melo RL; Guerreiro JR; Santos RA; Ulrich H; Lameu C
    Peptides; 2013 Oct; 48():124-33. PubMed ID: 23933300
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Effects of the angiotensin-converting enzyme inhibitor enalapril on blood haematopoietic progenitors and acetyl-N-Ser-Asp-Lys-Pro concentrations.
    Comte L; Lorgeot V; Volkov L; Allegraud A; Aldigier JC; Praloran V
    Eur J Clin Invest; 1997 Sep; 27(9):788-90. PubMed ID: 9352252
    [TBL] [Abstract][Full Text] [Related]  

  • 64. N-acetyl-seryl-aspartyl-lysyl-proline mediates the anti-fibrotic properties of captopril in unilateral ureteric obstructed BALB/C mice.
    Chan GCW; Wu HJ; Chan KW; Yiu WH; Zou A; Huang XR; Lan HY; Lai KN; Tang SCW
    Nephrology (Carlton); 2018 Apr; 23(4):297-307. PubMed ID: 28075040
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The lactotripeptides isoleucine-proline-proline and valine-proline-proline do not inhibit the N-terminal or C-terminal angiotensin converting enzyme active sites in humans.
    Wuerzner G; Peyrard S; Blanchard A; Lalanne F; Azizi M
    J Hypertens; 2009 Jul; 27(7):1404-9. PubMed ID: 19506528
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The N domain of human angiotensin-I-converting enzyme: the role of N-glycosylation and the crystal structure in complex with an N domain-specific phosphinic inhibitor, RXP407.
    Anthony CS; Corradi HR; Schwager SL; Redelinghuys P; Georgiadis D; Dive V; Acharya KR; Sturrock ED
    J Biol Chem; 2010 Nov; 285(46):35685-93. PubMed ID: 20826823
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Cleavage of arginyl-arginine and lysyl-arginine from the C-terminus of pro-hormone peptides by human germinal angiotensin I-converting enzyme (ACE) and the C-domain of human somatic ACE.
    Isaac RE; Williams TA; Sajid M; Corvol P; Coates D
    Biochem J; 1997 Dec; 328 ( Pt 2)(Pt 2):587-91. PubMed ID: 9371719
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Conversion of atriopeptin II to atriopeptin I by atrial dipeptidyl carboxy hydrolase.
    Harris RB; Wilson IB
    Peptides; 1985; 6(3):393-6. PubMed ID: 2999723
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Role of N-acetyl-seryl-aspartyl-lysyl-proline in the antifibrotic and anti-inflammatory effects of the angiotensin-converting enzyme inhibitor captopril in hypertension.
    Peng H; Carretero OA; Liao TD; Peterson EL; Rhaleb NE
    Hypertension; 2007 Mar; 49(3):695-703. PubMed ID: 17283252
    [TBL] [Abstract][Full Text] [Related]  

  • 70. In vivo modifications of AcSDKP metabolism and haematopoiesis in mice treated with 5-fluorouracil and Goralatide.
    Comte L; Lorgeot V; Bignon J; Volkov L; Dupuis F; Wdzieczak-Bakala J; Praloran V
    Eur J Clin Invest; 1998 Oct; 28(10):856-63. PubMed ID: 9793000
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The Plethora of Angiotensin-Converting Enzyme-Processed Peptides in Mouse Plasma.
    Semis M; Gugiu GB; Bernstein EA; Bernstein KE; Kalkum M
    Anal Chem; 2019 May; 91(10):6440-6453. PubMed ID: 31021607
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Role of rat intestinal brush-border membrane angiotensin-converting enzyme in dietary protein digestion.
    Yoshioka M; Erickson RH; Woodley JF; Gulli R; Guan D; Kim YS
    Am J Physiol; 1987 Dec; 253(6 Pt 1):G781-6. PubMed ID: 2827504
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A study of chimeras constructed with the two domains of angiotensin I-converting enzyme.
    Williams TA; Danilov S; Alhenc-Gelas F; Soubrier F
    Biochem Pharmacol; 1996 Jan; 51(1):11-4. PubMed ID: 8534262
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Molecular and thermodynamic mechanisms of the chloride-dependent human angiotensin-I-converting enzyme (ACE).
    Yates CJ; Masuyer G; Schwager SL; Akif M; Sturrock ED; Acharya KR
    J Biol Chem; 2014 Jan; 289(3):1798-814. PubMed ID: 24297181
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Different in vivo functions of the two catalytic domains of angiotensin-converting enzyme (ACE).
    Bernstein KE; Shen XZ; Gonzalez-Villalobos RA; Billet S; Okwan-Duodu D; Ong FS; Fuchs S
    Curr Opin Pharmacol; 2011 Apr; 11(2):105-11. PubMed ID: 21130035
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Angiotensin I-converting enzyme isoforms (high and low molecular weight) in urine of premature and full-term infants.
    Hattori MA; Del Ben GL; Carmona AK; Casarini DE
    Hypertension; 2000 Jun; 35(6):1284-90. PubMed ID: 10856278
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Effect of angiotensin-converting enzyme inhibition on plasma, urine, and tissue concentrations of hemoregulatory peptide acetyl-Ser-Asp-Lys-Pro in rats.
    Junot C; Nicolet L; Ezan E; Gonzales MF; Menard J; Azizi M
    J Pharmacol Exp Ther; 1999 Dec; 291(3):982-7. PubMed ID: 10565814
    [TBL] [Abstract][Full Text] [Related]  

  • 78. In silico identification of milk antihypertensive di- and tripeptides involved in angiotensin I-converting enzyme inhibitory activity.
    Vukic VR; Vukic DV; Milanovic SD; Ilicic MD; Kanuric KG; Johnson MS
    Nutr Res; 2017 Oct; 46():22-30. PubMed ID: 29173648
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Angiotensin converting enzyme (kininase II). Molecular and physiological aspects].
    Costerousse O; Jaspard E; Allegrini J; Wei L; Alhenc-Gelas F
    C R Seances Soc Biol Fil; 1992; 186(6):586-98. PubMed ID: 1339589
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Different contributions of the angiotensin-converting enzyme C-domain and N-domain in subjects with the angiotensin-converting enzyme II and DD genotype.
    van Esch JH; van Gool JM; de Bruin RJ; Payne JR; Montgomery HE; Hectors M; Deinum J; Dive V; Jan Danser AH
    J Hypertens; 2008 Apr; 26(4):706-13. PubMed ID: 18327080
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.